Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Exclusive: Chinese embassy lobbies U.S. business to oppose China bills - sources

Published 11/15/2021, 04:17 AM
Updated 11/15/2021, 04:26 AM
© Reuters. FILE PHOTO: The flags of the United States and China fly from a lamppost in the Chinatown neighborhood of Boston, Massachusetts, U.S., November 1, 2021.   REUTERS/Brian Snyder/File Photo

By Michael Martina

WASHINGTON (Reuters) - China has been pushing U.S. executives, companies and business groups in recent weeks to fight against China-related bills in the U.S. Congress, four sources familiar with the initiative told Reuters, in letters to and meetings with a wide range of actors in the business community.

China's embassy in Washington had sent letters pressing executives to urge members of Congress to alter or drop specific bills that seek to enhance U.S. competitiveness, according to the sources and the text of a letter sent by the embassy's economic and commercial office seen by Reuters.

Chinese officials warned companies they would risk losing market share or revenue in China if the legislation becomes law, according to the text of the letter.

The sources said China's request also left some individuals who received a letter concerned that they could be seen as violating the Foreign Agents Registration Act (FARA) if they lobbied lawmakers on similar issues in the future.

As a result, none of the sources wanted to be identified as having received or seen the letter.

China's foreign ministry spokesman Zhao Lijian said in response to a request for comment that certain bills distorted facts and were based on "Cold War thinking." If passed, he said, they would harm bilateral relations and cooperation between the two countries.

"China has always resolutely opposed this," he said at a daily briefing in Beijing.

Sweeping U.S. legislation to boost competition with China and fund much-needed semiconductor production, known as the U.S. Innovation and Competition Act (USICA), passed the Senate with bipartisan support in June. A related bill in the House of Representatives called the Eagle Act, which is more strictly policy focused, has stalled as Congress has been preoccupied with other domestic initiatives.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The language in the letters, which Reuters determined were sent separately to a wide number of people, explicitly asks companies to oppose USICA and the Eagle Act.

'NEGATIVE BILLS'

Beijing sees the measures, which take a hard line toward China on human rights and trade issues, as part of a U.S. effort to counter its growing economic and geopolitical might.

"We sincerely hope you ... will play a positive role in urging members of Congress to abandon the zero-sum mindset and ideological prejudice, stop touting negative China-related bills, delete negative provisions, so as to create favorable conditions for bilateral economic and trade cooperation before it is too late," the Chinese embassy said in one letter sent in early November.

Reuters confirmed the shared language of the letter with the four sources.

"The result of those China-related bills with negative impacts will not be that the interests of U.S. companies will be protected while those of Chinese companies will suffer. It is only going to hurt everyone," it said.

"Promoting a China-free supply chain will inevitably result in a decline in China's demand for U.S. products and American companies loss of market share and revenue in China," it said.

Two of the sources said similar messages were conveyed in meetings with staff of China's embassy.

"It's an outright ask by a foreign government," one of the sources said, highlighting the implications for FARA, which requires persons acting on behalf of a foreign power or political party to disclose those relations to the Department of Justice.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

A second source said the approach appeared geared at getting companies to delay the legislative process rather than block the bills entirely.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.